BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

http://ift.tt/2ouRsUN

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China  GlobeNewswire (press release)Full coverage

sekolah

via spm malaysia - Google News http://ift.tt/2DJ9HvA

February 28, 2018 at 07:06AM